Skip to content

Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer

A Standardized Nursing Intervention Protocol for Pancreatic Cancer as a Chronic Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00902733
Enrollment
125
Registered
2009-05-15
Start date
2008-07-31
Completion date
2010-02-28
Last updated
2010-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Nausea and Vomiting, Pain, Pancreatic Cancer

Keywords

pain, fatigue, nausea and vomiting, recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer

Brief summary

RATIONALE: Meeting with a nurse to assess symptoms and quality of life may be more effective than standard care in treating patients with pancreatic cancer. PURPOSE: This clinical trial is studying nurse-provided care to see how well it works compared with standard care in treating patients with pancreatic cancer.

Detailed description

OBJECTIVES: * To test the effects of an advanced practice nurse (APN) standardized nursing-intervention protocol (SNIP) model vs usual care on overall quality of life (QOL) and psychological distress from initial treatment to 6 months post diagnosis for patients with pancreatic cancer. * To compare symptom control in these patients. * To compare geriatric assessment outcomes in these patients. * To test the effects of the SNIP intervention as compared to the usual care group on resource use by these patients. * To test the effects of SNIP on patients' and clinicians' satisfaction with care. * To describe the effects of SNIP on patients' management of transitions from one phase of chronic illness to another. * To identify subgroups of these patients who benefit most from the SNIP in relation to sociodemographic characteristics, disease/treatment factors, and geriatric assessment predictors. * To obtain feedback from clinicians regarding interpretation of findings and application to the routine care of pancreatic cancer patients. OUTLINE: Patients are sequentially enrolled to 1 of 2 groups. Group 1 is enrolled during months 4-21 and group 2 during months 25-54. * Group 1 (usual care): Patient questionnaires are administered at baseline and at 3 and 6 months. The clinicians' satisfaction with care is also evaluated. * Group 2 (advanced practice nurse \[APN\] intervention): Patients are accrued by an APN. Patients meet with the APN periodically to assess their physical well-being including ambulatory care needed, care of physical symptoms (i.e., pain, fatigue, nausea and vomiting), and psychological well-being. Questionnaires are administered at baseline and at 3 and 6 months. In both groups, questionnaires include the FACT-Hep, Memorial Symptom Assessment Scale, Psychological Distress Thermometer, Comprehensive Geriatric Assessment, and Patient Satisfaction with Intervention. Clinicians also complete questionnaires. Patients' medical charts are also reviewed.

Interventions

OTHERmedical chart review
OTHERquestionnaire administration
PROCEDUREfatigue assessment and management
PROCEDUREpsychosocial assessment and care
PROCEDUREquality-of-life assessment

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
City of Hope Medical Center
Lead SponsorOTHER

Study design

Primary purpose
HEALTH_SERVICES_RESEARCH

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Diagnosis of pancreatic cancer (all stages) PATIENT CHARACTERISTICS: * Admitted to City of Hope National Medical Center * Resides within a 30-mile radius of the medical center * No prior cancer PRIOR CONCURRENT THERAPY: * No prior therapy

Design outcomes

Primary

MeasureTime frame
Quality of life, psychological distress, symptom relief, geriatric assessment outcome, and resource use at 3 months

Secondary

MeasureTime frame
Long-term impact at 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026